NASDAQ: ISPC
Ispecimen Inc Stock Ownership - Who owns Ispecimen?

Insider buying vs selling

Have Ispecimen Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ISPC insiders and whales buy or sell their stock.

ISPC Shareholders

What type of owners hold Ispecimen Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Andrew L. Ross158.25%3,951,388$4.88MInsider
George H. Scholl33.85%845,106$1.04MInsider
Obf Investments LLC33.72%841,981$1.04MInsider
Christopher Ianelli17.04%425,359$525.32kInsider
Jill Mullan9.86%246,226$304.09kInsider
Benjamin Bielak3.38%84,348$104.17kInsider
Tracy Curley1.98%49,541$61.18kInsider
Bridgeway Capital Management LLC0.87%21,800$26.92kInstitution
Ubs Group Ag0.44%10,974$13.55kInstitution
John L. Brooks Iii0.13%3,250$4.01kInsider

1 of 2

ISPC vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ISPC0.55%99.45%
CHEK2.33%0.00%
XWEL1.49%98.51%Net Buying
NDRA0.01%99.99%Net Buying
TRIB1.70%0.00%

Ispecimen Stock Ownership FAQ

Who owns Ispecimen?

Ispecimen (NASDAQ: ISPC) is owned by 1.43% institutional shareholders, 258.60% Ispecimen insiders, and 0.00% retail investors. Andrew L. Ross is the largest individual Ispecimen shareholder, owning 3.95M shares representing 158.25% of the company. Andrew L. Ross's Ispecimen shares are currently valued at $4.66M.

If you're new to stock investing, here's how to buy Ispecimen stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.